Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma.

Kim HJ, Park K, Kim JY, Kang G, Gwak G, Park I.

J Pathol Transl Med. 2017 Jul;51(4):403-409. doi: 10.4132/jptm.2017.03.18. Epub 2017 Jun 9.

2.

Magnetic resonance imaging and pathological characteristics of pure mucinous carcinoma in the breast according to echogenicity on ultrasonography.

Shin YG, Kim EK, Kim MJ, Yoon JH, Moon HJ.

Ultrasonography. 2017 Apr;36(2):131-138. doi: 10.14366/usg.16028. Epub 2016 Aug 29.

3.

Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.

Fu J, Wu L, Jiang M, Li D, Jiang T, Hong Z, Wang F, Li S.

PLoS One. 2016 Oct 19;11(10):e0164921. doi: 10.1371/journal.pone.0164921. eCollection 2016.

4.

Poorer Prognosis of Primary Signet-Ring Cell Carcinoma of the Breast Compared with Mucinous Carcinoma.

Wu X, Zhang Z, Li X, Lin Q, Chen G, Lu J, Zeng Y, Hu D, Huang K, Lin Z, Yan J.

PLoS One. 2016 Sep 1;11(9):e0162088. doi: 10.1371/journal.pone.0162088. eCollection 2016.

5.

The molecular background of mucinous carcinoma beyond MUC2.

Hugen N, Simons M, Halilović A, van der Post RS, Bogers AJ, Marijnissen-van Zanten MA, de Wilt JH, Nagtegaal ID.

J Pathol Clin Res. 2014 Nov 5;1(1):3-17. doi: 10.1002/cjp2.1. eCollection 2015 Jan. Review.

6.

Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.

Lei L, Yu X, Chen B, Chen Z, Wang X.

PLoS One. 2016 May 27;11(5):e0155132. doi: 10.1371/journal.pone.0155132. eCollection 2016.

7.

Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014).

Pan B, Yao R, Shi J, Xu QQ, Zhou YD, Mao F, Lin Y, Guan JH, Wang XJ, Zhang YN, Zhang XH, Shen SJ, Zhong Y, Xu YL, Zhu QL, Liang ZY, Sun Q.

Oncotarget. 2016 Jun 21;7(25):38864-38875. doi: 10.18632/oncotarget.8778.

8.

Atypical breasts cancers.

Wright L, Ng CE, Fasih T.

Int J Surg Case Rep. 2016;20:41-5. doi: 10.1016/j.ijscr.2016.01.008. Epub 2016 Jan 16.

9.

Mucinous Breast Cancer: a Review Study of 5 Year Experience from a Hospital-Based Series of Cases.

Dumitru A, Procop A, Iliesiu A, Tampa M, Mitrache L, Costache M, Sajin M, Lazaroiu A, Cirstoiu M.

Maedica (Buchar). 2015 Mar;10(1):14-8.

10.

Invasive mucinous carcinoma arising in ectopic axillary breast tissue: a case report and literature review.

Nardello SM, Kulkarni N, Aggon A, Boraas M, Sigurdson ER, Bleicher RJ.

Am J Case Rep. 2015 Mar 14;16:153-9. doi: 10.12659/AJCR.892650. Review.

11.

CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast.

García-Labastida L, Garza-Guajardo R, Barboza-Quintana O, Rodríguez-Sanchez IP, Ancer-Rodríguez J, Flores-Gutierrez JP, Gómez-Macías GS.

Biol Res. 2014 Sep 18;47:43. doi: 10.1186/0717-6287-47-43. Review.

12.

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.

Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V.

Oncologist. 2014 Aug;19(8):805-13. doi: 10.1634/theoncologist.2014-0108. Epub 2014 Jun 26.

13.

Mucinous breast cancer - clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002.

Sas-Korczyńska B, Mituś J, Stelmach A, Ryś J, Majczyk A.

Contemp Oncol (Pozn). 2014;18(2):120-3. doi: 10.5114/wo.2014.42727. Epub 2014 Jun 3.

14.

Pure mucinous breast carcinoma: a favorable subtype.

Yang M, Li X, Chun-Hong P, Lin-Ping H.

Breast Care (Basel). 2013 Mar;8(1):56-9. doi: 10.1159/000346828.

15.

Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma.

Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K.

Springerplus. 2013 Sep 23;2:481. doi: 10.1186/2193-1801-2-481. eCollection 2013.

16.

Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.

Nyante SJ, Dallal CM, Gierach GL, Park Y, Hollenbeck AR, Brinton LA.

Am J Epidemiol. 2013 Aug 1;178(3):359-71. doi: 10.1093/aje/kws471. Epub 2013 Jun 13.

17.

Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.

Tseng HS, Lin C, Chan SE, Chien SY, Kuo SJ, Chen ST, Chang TW, Chen DR.

World J Surg Oncol. 2013 Jun 14;11:139. doi: 10.1186/1477-7819-11-139.

18.

MicroRNA and histopathological characterization of pure mucinous breast carcinoma.

Zhou F, Li S, Meng HM, Qi LQ, Gu L.

Cancer Biol Med. 2013 Mar;10(1):22-7. doi: 10.7497/j.issn.2095-3941.2013.01.004.

19.

Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.

Baretta Z, Guindalini RS, Khramtsova G, Olopade OI.

Clin Breast Cancer. 2013 Apr;13(2):156-8. doi: 10.1016/j.clbc.2012.11.007. Epub 2012 Dec 29. No abstract available.

20.

Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Jambal P, Badtke MM, Harrell JC, Borges VF, Post MD, Sollender GE, Spillman MA, Horwitz KB, Jacobsen BM.

Breast Cancer Res Treat. 2013 Jan;137(2):431-48. doi: 10.1007/s10549-012-2377-x. Epub 2012 Dec 18.

Supplemental Content

Support Center